Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Catalent Pharma Solutions revenue
Catalent Pharma Solutions's revenue is $4.4 billion.
What is Catalent Pharma Solutions's revenue?
- Catalent Pharma Solutions peak revenue was $4.8B in 2022.
- Catalent Pharma Solutions annual revenue for 2023 was 4.3B, -11.22% growth from 2022.
- Catalent Pharma Solutions annual revenue for 2024 was 4.4B, 2.77% growth from 2023.
- Catalent Pharma Solutions's revenue growth from 2013 to 2024 is 143.35%.
- Catalent Pharma Solutions has 14,000 employees, and the revenue per employee ratio is $312,928.
- Catalent Pharma Solutions's peak quarterly revenue was $1.3B in 2024(q4).
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Catalent Pharma Solutions historical revenue
Catalent Pharma Solutions's peak revenue was $4.8B in 2022. The peak quarterly revenue was $1.3B in 2024(q4).
Catalent Pharma Solutions's revenue increased from $1.8b in 2013 to $4.4B currently. That's a 143.35% change in annual revenue.
Catalent Pharma Solutions annual revenue
Catalent Pharma Solutions annual revenue over time
| Fiscal year / year | Catalent Pharma Solutions revenue |
|---|---|
| 2013 | $1.8B |
| 2014 | $1.8B |
| 2015 | $1.8B |
| 2016 | $1.8B |
| 2017 | $2.1B |
| 2018 | $2.5B |
| 2019 | $2.5B |
| 2020 | $3.1B |
| 2021 | $4.0B |
| 2022 | $4.8B |
| 2023 | $4.3B |
| 2024 | $4.4B |
Rate Catalent Pharma Solutions' financial transparency
Catalent Pharma Solutions annual growth
Catalent Pharma Solutions saw the greatest revenue growth in 2021, when revenue increased by 29.22%.
Catalent Pharma Solutions had the lowest revenue growth in 2015, when revenue changed by 0.17%.
Catalent Pharma Solutions annual growth rate over time
| Year | Catalent Pharma Solutions growth |
|---|---|
| 2014 | 2%↑ |
| 2015 | 0%↑ |
| 2016 | 1%↑ |
| 2017 | 12%↑ |
| 2018 | 19%↑ |
| 2019 | 2%↑ |
| 2020 | 23%↑ |
| 2021 | 29%↑ |
| 2022 | 20%↑ |
| 2023 | -11%↓ |
| 2024 | 3%↑ |
Catalent Pharma Solutions quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Catalent Pharma Solutions quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $519.6M |
| 2015 | $418.3M | $455.8M | $446.6M | $510.1M |
| 2016 | $423.0M | $454.9M | $438.0M | $532.2M |
| 2017 | $442.2M | $483.7M | $532.6M | $616.9M |
| 2018 | $543.9M | $606.3M | $627.9M | $685.3M |
| 2019 | $551.8M | $623.0M | $617.5M | $725.7M |
| 2020 | $664.7M | $721.4M | $760.6M | $947.3M |
| 2021 | $846.0M | $911.0M | $1.1B | $1.2B |
| 2022 | $1.0B | $1.2B | $1.3B | $1.3B |
| 2023 | $1.0B | $1.1B | $1.0B | $1.1B |
| 2024 | $982.0M | $1.0B | $1.1B | $1.3B |
| 2025 | $1.0B | - | - | - |
Catalent Pharma Solutions jobs nearby
Do you work at Catalent Pharma Solutions?
Did Catalent Pharma Solutions meet its revenue projections?
Catalent Pharma Solutions financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 14,000 |
| Date Founded | 2007 |
| Headquarters | Somerset, New Jersey |
| Number of Locations | 23 |
| Revenue | $4.4B |
| Net Income | -$256,000,000 |
| Gross Proft | $953.0M (2024) |
| PE Ratio | -5.11 |
| Tax Rate | -0.0% |
| Market Capitalization | $5.3B |
| Total Assets | $10,777,000,000 |
| Ticker | CTLT |
Catalent Pharma Solutions jobs you might like
Catalent Pharma Solutions financing
Catalent Pharma Solutions received early financing of $550.0M on 2021-02-10.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $550M | 02/2021 |
Catalent Pharma Solutions competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Charles River Labs | $45,905 | $4.0B | 18,400 | 487 |
| Parexel International | $91,480 | $2.4B | 18,900 | 1,670 |
| Juniper Pharmaceuticals | $107,756 | $48.8M | 115 | - |
| West-Ward Pharmaceuticals | $59,065 | $150.0M | 249 | 62 |
| DPT Laboratories | $58,092 | $320.0M | 510 | 1 |
| Akorn | $62,397 | $682.4M | 2,227 | - |
| DSM Pharmaceuticals Inc | $53,992 | $850.0M | 1,200 | - |
| ALZA Corporation | $59,528 | $200.0M | 10,000 | - |
| Paddock Laboratories | $69,519 | $100.5M | 51 | - |
| Actavis Laboratories FL, Inc. | $68,450 | $162.9M | 900 | - |
Catalent Pharma Solutions revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Catalent Pharma Solutions highest paying jobs
Zippia gives an in-depth look into the details of Catalent Pharma Solutions, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Catalent Pharma Solutions. The employee data is based on information from people who have self-reported their past or current employments at Catalent Pharma Solutions. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Catalent Pharma Solutions. The data presented on this page does not represent the view of Catalent Pharma Solutions and its employees or that of Zippia.
Catalent Pharma Solutions may also be known as or be related to Catalent, Catalent Inc, Catalent Pharma Solutions and Catalent, Inc.